BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Prognosis
59 results:

  • 1. AKR1C3 silencing inhibits autophagy-dependent glycolysis in thyroid cancer cells by inactivating ERK signaling.
    Gao Y; Tao W; Wang S; Duan R; Zhang Z
    Drug Dev Res; 2024 Feb; 85(1):e22142. PubMed ID: 38349266
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
    Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
    Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. MEX3A induces the development of thyroid cancer via targeting CREB1.
    Feng G; Wang P; Zhang H; Cheng S; Xing Y; Wang Y
    Cell Biol Int; 2023 Nov; 47(11):1843-1853. PubMed ID: 37529875
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells.
    Simbolo M; Silvestris N; Malleo G; Mafficini A; Maggino L; Cocomazzi A; Veghini L; Mombello A; Pezzini F; Sereni E; Martelli FM; Gkountakos A; Ciaparrone C; Piredda ML; Ingravallo G; Paolino G; Nappo F; Rapposelli IG; Frassinetti L; Saragoni L; Lonardi S; Pea A; Paiella S; Fassan M; Brunetti O; Cingarlini S; Salvia R; Milella M; Corbo V; Lawlor RT; Scarpa A; Luchini C
    Mod Pathol; 2023 Sep; 36(9):100251. PubMed ID: 37355152
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical Impact of Androgen Receptor-Suppressing miR-146b Expression in Papillary Thyroid cancer Aggressiveness.
    Chou CK; Chi SY; Hung YY; Yang YC; Fu HC; Wang JH; Chen CC; Kang HY
    J Clin Endocrinol Metab; 2023 Oct; 108(11):2852-2861. PubMed ID: 37220080
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MicroRNA-130a-3p impedes the progression of papillary thyroid carcinoma through downregulation of KPNB1 by targeting PSME3.
    Wang Y; Xu J; Zhu X; Kuang H
    Endocrine; 2023 Oct; 82(1):96-107. PubMed ID: 37166548
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. TESC promotes differentiated thyroid cancer development by activating ERK and weakening NIS and radioiodine uptake.
    Guo Y; Cai Y; Song F; Zhu L; Hu Y; Liu Y; Ma W; Ge J; Zeng Q; Ding L; Li L; Zheng G; Ge M
    Endocrine; 2023 Sep; 81(3):503-512. PubMed ID: 37020077
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
    Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
    Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma.
    Chen X; Ma H; Mo S; Yu S; Lu Z; Chen J
    Front Immunol; 2022; 13():1027459. PubMed ID: 36325339
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An integrative pan cancer analysis of RET aberrations and their potential clinical implications.
    Zhou L; Li J; Zhang X; Xu Z; Yan Y; Hu K
    Sci Rep; 2022 Aug; 12(1):13913. PubMed ID: 35978072
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma.
    Chen X; Ma H; Mo S; Zhang Y; Lu Z; Yu S; Chen J
    Front Immunol; 2022; 13():942154. PubMed ID: 35936015
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Histone deacetylase inhibitor, panobinostat, exerts anti-proliferative effect with partial normalization from aberrant epigenetic states on granulosa cell tumor cell lines.
    Hazama Y; Tsujioka T; Kitanaka A; Tohyama K; Shimoya K
    PLoS One; 2022; 17(7):e0271245. PubMed ID: 35802681
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mIHC and spatial distribution analysis.
    Zhu Y; Chen J; Liu Y; Zheng X; Feng J; Chen X; Jiang T; Li Y; Chen L
    Pathol Res Pract; 2022 Jun; 234():153911. PubMed ID: 35489125
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. NOD1 activation promotes cell apoptosis in papillary thyroid cancer.
    Bai N; Liu C; Zhang X; Cheng Y; Hou D
    Pathol Res Pract; 2022 May; 233():153880. PubMed ID: 35430507
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer.
    Si S; Wang L; Cao H; Xu Y; Zhan Q
    BMC Cancer; 2022 Feb; 22(1):211. PubMed ID: 35219310
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Machine learning algorithms are comparable to conventional regression models in predicting distant metastasis of follicular thyroid carcinoma.
    Mao Y; Lan H; Lin W; Liang J; Huang H; Li L; Wen J; Chen G
    Clin Endocrinol (Oxf); 2023 Jan; 98(1):98-109. PubMed ID: 35171531
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. MicroRNA-99a-3p/GRP94 axis affects metastatic progression of human papillary thyroid carcinoma by regulating ITGA2 expression and localization.
    Gao Y; Pan Y; Wang T; Yao Y; Yuan W; Zhu X; Wang K
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1650-1661. PubMed ID: 34687203
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma.
    Wang T; Tian K; Ji X; Song F
    Medicine (Baltimore); 2021 Oct; 100(40):e27308. PubMed ID: 34622829
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma.
    Stosic A; Fuligni F; Anderson ND; Davidson S; de Borja R; Acker M; Forte V; Campisi P; Propst EJ; Wolter NE; Chami R; Mete O; Malkin D; Shlien A; Wasserman JD
    Cancer Res; 2021 Nov; 81(22):5625-5637. PubMed ID: 34535459
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomas.
    Niu N; Shen W; Zhong Y; Bast RC; Jazaeri A; Sood AK; Liu J
    Hum Pathol; 2021 Jul; 113():20-27. PubMed ID: 33887301
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.